Eligibility Limited for Anti-β Amyloid mAbs in Seniors With MCI
Few older adults with MCI or mild dementia were eligible for lecanemab, aducanumab after applying clinical trial criteria
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.